Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group
- PMID: 7678730
- DOI: 10.1001/archopht.1993.01090010108035
Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group
Erratum in
- Arch Ophthalmol 1993 Nov;111(11):1499
- Arch Ophthalmol 1993 Sep;111(9):1228, 1993 Oct;111(10):1366
Abstract
We evaluated the hypothesis that higher serum levels of micronutrients with antioxidant capabilities may be associated with a decreased risk of neovascular age-related macular degeneration by comparing serum levels of carotenoids, vitamins C and E, and selenium in 421 patients with neovascular age-related macular degeneration and 615 controls. Subjects were classified by blood level of the micronutrient (low, medium, and high). Persons with carotenoid levels in the medium and high groups, compared with those in the low group, had markedly reduced risks of neovascular age-related macular degeneration, with levels of risk reduced to one half and one third, respectively. Although no statistically significant protective effect was found for vitamin C or E or selenium individually, an antioxidant index that combined all four micronutrient measurements showed statistically significant reductions of risk with increasing levels of the index. Although these results suggest that higher blood levels of micronutrients with antioxidant potential, in particular, carotenoids, may be associated with a decreased risk of the most visually disabling form of age-related macular degeneration, it would be premature to translate these findings into nutritional recommendations.
Similar articles
-
Serum antioxidants and age-related macular degeneration in a population-based case-control study.Arch Ophthalmol. 1995 Dec;113(12):1518-23. doi: 10.1001/archopht.1995.01100120048007. Arch Ophthalmol. 1995. PMID: 7487619
-
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.JAMA. 1994 Nov 9;272(18):1413-20. JAMA. 1994. PMID: 7933422
-
[Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type)].Nippon Ganka Gakkai Zasshi. 1997 Mar;101(3):248-51. Nippon Ganka Gakkai Zasshi. 1997. PMID: 9086745 Japanese.
-
Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins.Am J Clin Nutr. 1995 Dec;62(6 Suppl):1448S-1461S. doi: 10.1093/ajcn/62.6.1448S. Am J Clin Nutr. 1995. PMID: 7495246 Review.
-
Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration - the potential sources and molecular cues for their recruitment and activation.EBioMedicine. 2018 Dec;38:283-291. doi: 10.1016/j.ebiom.2018.11.029. Epub 2018 Nov 22. EBioMedicine. 2018. PMID: 30473378 Free PMC article. Review.
Cited by
-
Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases.Molecules. 2022 Sep 15;27(18):6005. doi: 10.3390/molecules27186005. Molecules. 2022. PMID: 36144741 Free PMC article. Review.
-
Epidemiology of age-related maculopathy: a review.Eur J Epidemiol. 2003;18(9):845-54. doi: 10.1023/a:1025643303914. Eur J Epidemiol. 2003. PMID: 14561043 Review.
-
Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans.Lipids. 2005 Oct;40(10):1013-22. doi: 10.1007/s11745-005-1464-3. Lipids. 2005. PMID: 16382573 Clinical Trial.
-
The macular carotenoids: A biochemical overview.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Nov;1865(11):158617. doi: 10.1016/j.bbalip.2020.158617. Epub 2020 Jan 10. Biochim Biophys Acta Mol Cell Biol Lipids. 2020. PMID: 31931175 Free PMC article. Review.
-
Vascular endothelial growth factor in eye disease.Prog Retin Eye Res. 2008 Jul;27(4):331-71. doi: 10.1016/j.preteyeres.2008.05.001. Epub 2008 May 28. Prog Retin Eye Res. 2008. PMID: 18653375 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical